These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26279360)

  • 1. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.
    Egwuagu CE; Yu CR; Sun L; Wang R
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):587-93. PubMed ID: 26279360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Regulatory B Cells in Experimental Autoimmune Uveitis.
    Choi JK; Egwuagu CE
    Methods Mol Biol; 2021; 2270():437-450. PubMed ID: 33479912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 35 Regulatory B Cells.
    Choi JK; Egwuagu CE
    J Mol Biol; 2021 Jan; 433(1):166607. PubMed ID: 32755620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.
    Egwuagu CE; Yu CR
    Crit Rev Immunol; 2015; 35(1):49-57. PubMed ID: 25746047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
    Kang M; Choi JK; Jittayasothorn Y; Egwuagu CE
    Front Immunol; 2020; 11():1051. PubMed ID: 32547555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases.
    Choi JK; Yu CR; Bing SJ; Jittayasothorn Y; Mattapallil MJ; Kang M; Park SB; Lee HS; Dong L; Shi G; Caspi RR; Egwuagu CE
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunobiology of Interleukin-35 and Its Regulation and Gene Expression.
    Song M; Ma X
    Adv Exp Med Biol; 2016; 941():213-225. PubMed ID: 27734415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-35 is a critical regulator of immunity during helminth infections associated with multiple sclerosis.
    Correale J; Marrodan M; Carnero Contentti E
    Immunology; 2021 Nov; 164(3):569-586. PubMed ID: 34197631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.
    Yu CR; Choi JK; Uche AN; Egwuagu CE
    J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible role of interleukin-35 and its therapeutic potential in pemphigus.
    Tavakolpour S; Kheiry F; Mirsafaei HS; Akhlaghdoust M
    Int Immunopharmacol; 2017 Jan; 42():11-17. PubMed ID: 27855302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-35 and Autoimmunity: a Comprehensive Perspective.
    Choi J; Leung PS; Bowlus C; Gershwin ME
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):327-32. PubMed ID: 25619872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTB driven B cells producing IL-35 and secreting high level of IL-10 in the patients with active pulmonary tuberculosis.
    Dai YC; Wang WD; Zhang JA; Chen C; Luo HL; Xu H; Peng Y; Luo H; Yang XR; Chen X; Wu XJ; Chen GH; Chen ZW; Xu JF
    Mol Immunol; 2019 Aug; 112():175-181. PubMed ID: 31170628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.
    Dambuza IM; He C; Choi JK; Yu CR; Wang R; Mattapallil MJ; Wingfield PT; Caspi RR; Egwuagu CE
    Nat Commun; 2017 Sep; 8(1):719. PubMed ID: 28959012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
    Quan S; Sheng JR; Abraham PM; Soliven B
    Clin Exp Immunol; 2016 Apr; 184(1):50-61. PubMed ID: 26671281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.
    Sun L; He C; Nair L; Yeung J; Egwuagu CE
    Cytokine; 2015 Oct; 75(2):249-55. PubMed ID: 25796985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory B cells in ANCA-associated vasculitis.
    Wilde B; Thewissen M; Damoiseaux J; Knippenberg S; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
    Ann Rheum Dis; 2013 Aug; 72(8):1416-9. PubMed ID: 23666929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells.
    Hao S; Chen X; Wang F; Shao Q; Liu J; Zhao H; Yuan C; Ren H; Mao H
    Carcinogenesis; 2018 Dec; 39(12):1488-1496. PubMed ID: 30321288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding family of regulatory B cells.
    Mauri C; Menon M
    Int Immunol; 2015 Oct; 27(10):479-86. PubMed ID: 26071023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.